Skip to main
CME
CME logo

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 8%
Buy 33%
Hold 42%
Sell 17%
Strong Sell 0%

Bulls say

CME Group has demonstrated strong financial performance, achieving record revenue of $1.7 billion, which reflects a 10% increase year-over-year, supported by significant growth in both Clearing & Transaction and Market Data revenue. The company also experienced robust international expansion, with record quarterly volume driven by EMEA (15% increase year-over-year) and APAC (30% increase year-over-year), indicating a broadening market reach. Additionally, CME Group successfully attracted over 90,000 new retail traders, marking a 56% year-over-year growth and representing the fifth consecutive quarter of double-digit growth in this segment.

Bears say

CME Group faces significant risks that could negatively impact its stock performance, primarily due to the potential decline in open interest (OI), which may lead to deteriorating sentiment and financial conditions. Moreover, regulatory risks such as increased margin requirements and limitations on trading practices can reduce trading volumes, while the company's heavy reliance on market volatility exacerbates its vulnerability to low volatility conditions. Additionally, changes in industry fundamentals, competitive dynamics, or unforeseen management issues may adversely affect expected revenues, earnings, and overall investor confidence in CME Group.

CME Group (CME) has been analyzed by 12 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 33% recommend Buy, 42% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 12 analysts, CME Group (CME) has a Hold consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $276.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $276.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.